oneplacenewsSource: ScienceDaily Health
Summary
Many patients prescribed GLP-1 drugs like Ozempic for type 2 diabetes often discontinue treatment but frequently return later. New research highlights that newer medications help patients stay on therapy longer, although side effects continue to pose challenges.
Why It Matters
Understanding the patterns of GLP-1 drug discontinuation can provide insights into patient adherence and the efficacy of treatments. The resurgence of patients returning to therapy emphasizes the need for ongoing support and management of side effects. This information is crucial for healthcare providers to design better treatment plans that address patient concerns and improve long-term outcomes.
